Cyclosporine-induced graft vs host disease in two patients receiving syngeneic bone marrow transplants
Dale, B.M.; Atkinson, K.; Kotasek, D.; Biggs, J.C.; Sage, R.E.
Transplantation Proceedings 21(5): 3816-3817
1989
ISSN/ISBN: 0041-1345 PMID: 2815290 Document Number: 342951
Document emailed within 1 workday
Related Documents
Johnsen, H.E.; Mickelson, E.; Beatty, P.G.; Hansen, J.A. 1992: Donor alloreactivity may predict acute graft-versus-host disease in patients receiving marrow transplants from HLA identical siblings Bone Marrow Transplantation 9(2): 91-96Hess, A.D.; Vogelsang, G.B.; Heyd, J.; Beschorner, W.E. 1987: Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation Transplantation Proceedings 19(1 Part 3): 2683-2686
Gluckman, E.; Devergie, A.; Sohier, J.; Saurat, J.H. 1980: Graft-versus-host disease in recipients of syngeneic bone marrow Lancet 1(8162): 253-254
Cooper, M.H.; Hartman, G.G.; Starzl, T.E.; Fung, J.J. 1991: The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506 Transplantation Proceedings 23(6): 3234-3235
Spaner, D.; Lowsky, R.; Fyles, G.; Lipton, J.H.; Banerjee, D.; Ng, C.M.; Wade, J.A.; Messner, H.A. 1998: Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient Transplantation 66(9): 1251-1253
Sullivan, K.M.; Siadak, M.F.; Witherspoon, R.P. 1990: Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation Transplantation Proceedings 22(3): 1336-1338
Lachance, S.; Le Gouvello, S.; Roudot, F.; Kuentz, M.; Bernaudin, F.; Beaujean, F.; Bierling, P.; Cordonnier, C.; Farcet, J.P.; Vernant, J.P. 1997: Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies Transplantation 64(8): 1147-1152
Mrsić, M.; Labar, B.; Bogdanić, V.; Nemet, D.; Pavletić, Z.; Plavsić, F.; Dobrić, I.; Kastelan, A.; Marusić, M.; Zupancić-Salek, S. 1989: Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias Bone Marrow Transplantation 4(Suppl): 95-96
Przepiorka, D.; Shapiro, S.; Schwinghammer, T.L.; Bloom, E.J.; Rosenfeld, C.S.; Shadduck, R.K.; Venkataramanan, R. 1991: Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease Bone Marrow Transplantation 7(6): 461-465
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Contassot, E.; Ferrand, C.; Angonin, R.; Cohen, J.L.; de Carvalho Bittencourt, M.; Lorchel, F.; Laithier, V.; Cahn, J.Y.; Klatzmann, D.; Herve, P.; Tiberghien, P. 2000: Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting Transplantation 69(4): 503-508
Oluwole, S.F.; Engelstad, K.; Hardy, M.A. 1992: Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum Transplantation Proceedings 24(6): 2858-2859
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476
Jansen, J.; Goselink, H.M.; Veenhof, W.F.; Zwaan, F.E.; Blotkamp, C. 1983: The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease Experimental Hematology 11(10): 967-973
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Liem, L.M.; van Noort, J.T.; Goulmy, E. 1996: Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin a Bone Marrow Transplantation 18(1): 73-78
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Sakamoto, K.; Sachs, D.H.; Shimada, S.; Popitz-Bergez, F.A.; Pennington, L.R.; Pescovitz, M.D.; McDonough, M.A.; MacVittie, T.J.; Katz, S.I.; Gress, R.E. 1988: Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow Transplantation 45(5): 869-875
Bykova, T.A.; Kozlov, A.V.; Stancheva, N.V.; Semënova, E.V.; Kulagina, I.I.; Bondarenko, S.N.; Vavilov, V.N.; Morozova, E.V.; Zubarovskaia, L.S.; Afanas'ev, B.V. 2013: Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation Terapevticheskii Arkhiv 85(8): 60-68